News & Insights
Stay up to date on PsychoGenics’ latest research, press releases, and industry developments in preclinical drug discovery. Combine our expertise with yours to spark the translational power of your next CNS breakthrough.
Filters
Filters
Therapeutic Areas
In Vivo AI Platforms
Mental Illness
Neurodegenerative Disorders
Neurodevelopmental Disorders
Neuromuscular Disorders
Pain
Sleep & Seizure Disorders
Rare CNS Disorders
Traumatic Brain Injury
Specific Disorders
Apply Filters
Filters
PUBLICATION
Comprehensive Analysis of the 16p11.2 Deletion and Null Cntnap2 Mouse Models of Autism Spectrum Disorder.
September 26, 2015
PUBLICATION
High-throughtput analysis of behavior for drug discovery
March 5, 2015
PUBLICATION
Effect of a novel, orally active matrix metalloproteinease-2 and-9 inhibitor in spinal and trigeminal rat models of neuropathic pain
September 1, 2014
PUBLICATION
Animal Models of Huntington’s Disease for Translation to the Clinic: Best Practices. Movement Disorders
August 26, 2014
PUBLICATION
Genetic Deletion of Transglutaminase 2 Does Not Rescue the Phenotypic Deficits Observed in R6/2 and zQ175 Mouse Models of Huntington’s Disease
June 25, 2014
PUBLICATION
Phenotypic Characterization of Recessive Gene Knockout Rat Models of Parkinson’s Disease
June 24, 2014
PUBLICATION
High-Throughput Automated Phenotyping of Two Genetic Mouse Models of Huntington’s Disease.
July 26, 2013
PUBLICATION
Regional Vulnerability in Huntington’s disease: fMRI-guided Molecular Analysis in Patients and a Mouse Model of disease
April 1, 2013
PUBLICATION
Comprehensive Behavioral and Molecular characterization of a new knock-in Mouse Model of Huntington’s disease: zQ175
October 26, 2012